secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2024-10-17T23:59:59+00:00
Accession:  0001104659-24-109575
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Petros Pharmaceuticals amends Series A Preferred to grant voting rights at $2.25 conversion price
--------------------------------------------------------------------------------

- Amendment grants Series A Preferred holders voting rights on as-converted basis at $2.25/share conversion price.
- Certificate of Amendment filed with Delaware Secretary of State, effective October 11, 2024.
- Required Holders (majority of outstanding preferred) agreed; no additional consideration paid to investors.
- Amendment modifies terms from original July 2023 Securities Purchase Agreement; no other changes to transaction documents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465924109575/0001104659-24-109575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465924109575/tm2426416d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-109575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer